Castelli Jeff 4
4 · AMICUS THERAPEUTICS, INC. · Filed Nov 26, 2025
Insider Transaction Report
Form 4
Castelli Jeff
Chief Development Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-24$9.03/sh+50,000$451,500→ 515,476 total - Sale
Common Stock
2025-11-24$10.16/sh−76,158$773,659→ 439,318 total - Exercise/Conversion
Stock Options (right to buy)
2025-11-24−50,000→ 0 totalExercise: $9.03Exp: 2026-01-04→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.00 to $10.51 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]All of the options were fully vested and exercisable as of the transaction date.